StockDriftsStockDriftsTop 19 Foresite Capital Management VI LLC Holdings
| Stock | Company | % Port. | Shares | Value | Activity | Ownership | Avg. Cost | Date |
|---|---|---|---|---|---|---|---|---|
| CGON | CG Oncology, Inc. | 26.2% | 2.37M | $168.4M | +6.67%(+148.10K) | $35.35(+112.26%) | 2026-06-30 | |
| ALMS | ALUMIS INC. | 18.6% | 4.25M | $119.5M | +0.00%(+0) | $9.22(+174.58%) | 2026-06-30 | |
| DNLI | Denali Therapeutics Inc. | 5.59% | 1.40M | $35.9M | +15.44%(+186.80K) | $15.82(+54.25%) | 2026-06-30 | |
| CLDX | Celldex Therapeutics, Inc. | 5.09% | 879.7K | $32.7M | +178.47%(+563.80K) | $31.94(+31.33%) | 2026-06-30 | |
| AGIO | AGIOS PHARMACEUTICALS, INC. | 4.53% | 785.0K | $29.1M | +49.52%(+260.00K) | $33.57(-0.04%) | 2026-06-30 | |
| CRVS | Corvus Pharmaceuticals, Inc. | 4.26% | 1.83M | $27.4M | +0.00%(+0) | $6.65(+124.03%) | 2026-06-30 | |
| GHRS | GH Research PLC | 3.93% | 940.5K | $25.3M | +198.10%(+625.00K) | $17.75(+66.15%) | 2026-06-30 | |
| JBIO | Jade Biosciences, Inc. | 3.07% | 886.7K | $19.7M | +177.08%(+566.67K) | $16.66(+48.34%) | 2026-06-30 | |
| HNGE | Hinge Health, Inc. | 2.85% | 220.4K | $18.3M | +0.00%(+0) | $48.17(+83.71%) | 2026-06-30 | |
| KYMR | Kymera Therapeutics, Inc. | 2.61% | 146.3K | $16.8M | +0.00%(+0) | $43.78(+168.14%) | 2026-06-30 |
| Performance Metric | 3-Year Annualized | 3-Year Cumulative | 5-Year Annualized | 5-Year Cumulative | Since First Filing (6 quarters) |
|---|---|---|---|---|---|
| Top 20 Holdings Weighted | — | — | — | — | +100.89% |
| Top 20 Holdings Unweighted | — | — | — | — | +89.65% |
Foresite Capital Management VI LLC reports $642.58M in US-listed equity holdings across 23 positions in its most recent 13F filing. Its largest disclosed positions are CGON (26.2%), ALMS (18.6%) and DNLI (5.6%). The top 20 holdings account for 89.08% of reported assets. Its disclosed equity book has returned +100.89% cumulatively over 6 quarters. Figures reflect the Q2 2026 filing.
Portfolio changes
Every reported change this quarter, grouped by direction. The signal is in the rotation, not any single trade.
Sign up free to track Foresite Capital Management VI LLC, compare funds side by side, and get alerts the moment positions change.
Holdings on this page are parsed from Foresite Capital Management VI LLC’s Form 13F filings with the U.S. Securities and Exchange Commission (CIK 2013341). View Foresite Capital Management VI LLC’s 13F filings on SEC